The goal of this study is to: 1. assess the feasibility, acceptability, and the preliminary effects of the health chat for empowerment-based lifestyle planning for CMM (HcELP\_CMM); 2. examine the short-term effects of the HcELP\_CMM program on lifestyle behaviors, cardiometabolic indicators, symptom burden, health related quality of life (HRQoL), psychological well-being, and physical function in patients with CMM; 3. examine the long-term effects of the HcELP\_CMM program on lifestyle behaviors, cardiometabolic indicators, symptom burden, HRQoL, psychological well-being, and physical function in patients with CMM. The main questions it aims to answer are: 1. If the HcELP\_CMM program is feasible and acceptable? 2. If the HcELP\_CMM program has the potential to improve the lifestyle behaviors, cardiometabolic indicators, symptom burden, HRQoL, psychological well-being, and physical function in patients with CMM compared to the usual care group in the short-term？ 3. If the HcELP\_CMM program has the potential to improve the lifestyle behaviors, cardiometabolic indicators, symptom burden, HRQoL, psychological well-being, and physical function in patients with CMM compared to the usual care group in the long-term？
Age range
18 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
Eligibility rate
Timeframe: Eligibility rate will be assessed at baseline only in the pilot part.
Recruitment rate
Timeframe: Recruitment rate will be assessed at baseline only in the pilot part.
Adherence rate
Timeframe: Adherence rate will be assessed through study completion (an average of 12 weeks) in the pilot part only.
Reasons for refusal to participate the program
Timeframe: Reasons for refusal to participate the program will be assessed at baseline only in the pilot part.
Participant's engagement experiences, feedback about the study design, and perceived program effects.
Timeframe: Participant's engagement experiences, feedback about the study design, and perceived program effects will be measured within one week after the completion of the intervention only in the pilot part.
Attrition rate
Timeframe: Attrition rate will be assessed through study completion (an average of 12 weeks) in the pilot part only.
Engagement rate
Timeframe: Engagement rate will be assessed through study completion (an average of 12 weeks) in the pilot part only.
Reasons of non-engagement
Timeframe: Reasons of non-engagement will be assessed through study completion (an average of 12 weeks) in the pilot part only.
Exposure to empowerment videos
Timeframe: Exposure to empowerment videos will be assessed through study completion (an average of 12 weeks) in the pilot part only.
Completion rate
Timeframe: Completion rate will be assessed through study completion (an average of 12 weeks) in the pilot part only.
Goal attainment level
Timeframe: Goal attainment level will be assessed through study completion (an average of 12 weeks) in the pilot part only.
Researcher-participant dialogues
Timeframe: Researcher-participant dialogues will be assessed through study completion (an average of 12 weeks) in the pilot part only.
Adverse events
Timeframe: Adverse events will be assessed through study completion (an average of 12 weeks) in the pilot part only.